Autologous transplant in elderly leukemia 2 Graphical abstractElderly AML patients above 65 years derive similar benefits in overall survival from ASCT consolidation in CR1 as AML patients below 65 years. Highlights

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

No abstract